Martial arts legend Richard Norton died after injecting experimental peptides for recovery and muscle loss
Hollywood stuntman and martial arts legend Richard Norton died after injecting unapproved peptides, according to newly released findings from an Australian coroner. The 75-year-old suffered cardiac arrest in March 2025 after using two experimental substances commonly promoted for muscle growth, recovery, and anti-aging benefits.
The findings, released Wednesday, October 28, come at a particularly significant time. Just as Australian authorities are considering tougher restrictions on experimental peptides, the United States government has announced a new policy allowing licensed pharmacies to compound six popular peptides, including BPC-157 and TB-500.
Coroner Links Richard Norton’s Death to Peptide Injections
According to Australia’s ABC News, Victorian coroner David Ryan determined that Norton’s death was triggered by complications arising from injections of CJC-1295 and ipamorelin.
A medical practitioner prescribed both substances despite lacking approval from Australia’s Therapeutic Goods Administration.
Norton had sought peptide therapy to address several physical concerns.
The actor underwent surgeries on both shoulders and sought treatments to improve his physical condition.
On March 19, 2025, Norton received prescriptions for CJC-1295 and ipamorelin after undergoing blood tests and signing an informed consent form acknowledging potential risks.
Initially, Norton reported feeling better.
However, investigators reportedly discovered that he had been administering twice the prescribed dosage.
On March 28, Norton informed a nurse about the increased doses and was advised to return to the prescribed amount.
Hours later, after injecting the substances, Norton experienced flushing and became unresponsive.
He suffered cardiac arrest and died at Melbourne’s Alfred Hospital on March 30, 2025.
The coroner determined that complications associated with the peptide injections triggered his death.
Medical Experts Raise Serious Concerns About Experimental Peptides
Following Norton’s death, the Medical Board of Australia investigated the treatment provided by his physician, Dr. Jerzy Muchnicki.
An independent medical expert concluded that there was insufficient evidence demonstrating that CJC-1295 and ipamorelin were safe and effective.
The investigation also identified shortcomings in the physician’s medical documentation. Muchnicki acknowledged the criticism, expressed regret, and committed to improving his practices.
Coroner David Ryan subsequently recommended that Australia’s TGA review the safety and therapeutic benefits of the substances and consider imposing additional restrictions.
The review could include moving the peptides from prescription-only status into a more restrictive category generally reserved for experimental or clinical research use.
CJC-1295 and ipamorelin are frequently promoted for their effects on growth hormone signaling. However, claims about improved muscle growth, recovery, and anti-aging benefits have not been established through sufficient human clinical research.
U.S. Government Moves to Expand Access to Popular Peptides
The Australian findings arrive during a major regulatory shift in the United States.
On October 28, the U.S. Department of Health and Human Services announced an interim policy permitting certain licensed pharmacies and physicians to compound six previously restricted peptides under specific conditions.
The substances include:
- BPC-157
- TB-500
- MOTS-c
- Epitalon
- KPV
- Semax
BPC-157 and TB-500 have attracted considerable attention in bodybuilding circles because of claims that they may accelerate recovery from muscle, tendon, and ligament injuries.
Under the new federal policy, qualifying compounders can prepare these substances for individual patients while the FDA continues reviewing their regulatory status.
The policy requires patient-specific prescriptions, ingredient traceability, quality testing, and safety reporting.
Importantly, the decision does not mean these peptides have received FDA approval or have been proven safe and effective.
The six substances covered by the new American policy are also different from CJC-1295 and ipamorelin, the two peptides implicated in Norton’s death.
According to Reuters, federal officials argue that allowing regulated compounding could help reduce reliance on questionable overseas suppliers and unregulated online sellers.
However, critics warn that expanding access to experimental substances without adequate human safety data could expose patients to serious health risks.
Richard Norton Was a Hollywood Martial Arts Legend
The Australian-born martial artist worked alongside some of Hollywood’s biggest action stars, including Chuck Norris, and established a successful career as an actor, stunt performer, fight choreographer, and martial arts instructor.
His credits included Mad Max: Fury Road, Mad Max: Furiosa, and numerous martial arts films.
Fans knew Norton for his exceptional physical conditioning, and he remained committed to fitness throughout his life.
His death has brought renewed attention to the potential dangers of experimental performance and recovery substances, particularly among older athletes seeking to maintain muscle mass and physical function.
As the popularity of peptides continues growing throughout the fitness industry, Norton’s case serves as a significant reminder that medical supervision and a prescription do not necessarily establish a substance’s safety.
The Australian coroner’s findings and the new American compounding policy now place the debate over experimental peptides firmly in the spotlight.
Header image embed via Instagram @rjnorton70
